Clin2
NCT07552480Possibly a fitNot yet recruiting

Can goserelin protect ovaries during stem cell transplant?

Allogeneic Haematopoietic Stem Cell TransplantationMalignant Hematologic DiseaseOvarian Insufficiency

Treatments studied

Part of Blood & lymphatic, Cancer, Women’s health & pregnancy clinical trials.

This study tests whether a medicine called goserelin (Zoladex) can help protect your ovaries during a stem cell transplant, so your periods may come back after treatment. If you qualify, you would receive this medicine as part of your transplant care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
64 people
Ages
14 years to 50 years
Study type
Interventional

Who can take part

  • You have a blood cancer or similar blood disorder and are scheduled for a stem cell transplant.
  • You are a woman between 14 and 50 years old, and you had regular monthly periods before the transplant.
  • You are willing to sign a consent form and follow the study steps.
  • Your doctor expects you to live for more than a year so they can track whether your periods return.
  • You do not have severe heart, liver, or kidney disease, and you are not allergic to goserelin (Zoladex).
  • You have not gone through menopause yet, and you do not have conditions like PCOS or endometriosis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07552493Not yet recruiting
Protecting ovarian function during stem cell transplant with goserelin

This study tests whether a medicine called goserelin can help protect your ovaries and keep your menstrual cycle regular during a stem cell transplant. If you are a woman planning this transplant, it may help preserve your fertility and hormone health.

Zhengzhou, Henan
NCT07552506Not yet recruiting
Goserelin to preserve ovarian function in aplastic anemia stem cell transplant patients

This study tests whether a medication called goserelin (which temporarily 'puts the ovaries to sleep') can help protect ovarian function in women with aplastic anemia who are having a stem cell transplant. The goal is to see if it helps preserve the chance of getting your period back after the transplant.

Zhengzhou, Henan
NCT07460752Recruiting· Phase 2
Alternative injection site for goserelin in breast cancer patients

This trial is testing whether giving the drug goserelin in a different spot on the body works just as well for suppressing ovarian function in premenopausal women with hormone receptor positive breast cancer. You may be a fit if you've already been on goserelin shots in your abdomen for at least 6 months.

Rochester, Minnesota
NCT07158021Recruiting· Phase 2
Comparing two ovarian suppression drugs for breast cancer

This trial tests two hormone-blocking injections (leuprolide and goserelin) to suppress ovarian function in premenopausal women with breast cancer. It aims to see how well these drugs work when taken with standard hormone pills.

Ann Arbor, Michigan
NCT06513962Recruiting· Phase 3
Triptorelin to protect ovaries in young women with cancer

This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.

Birmingham, Alabama
NCT06904599Recruiting· Phase 2
Testing hCG for acute GVHD after a stem cell transplant

This study tests if a hormone called hCG can help treat moderate-to-severe graft-versus-host disease (GVHD) after a stem cell transplant. It is for adults who have recently developed GVHD and need steroids, but have not been on high-dose steroids for long.

Monterrey, Nuevo León

Hear when a new Ovarian Insufficiency trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.